Ribonuclease-Activated Cancer Prodrug-Reference-Cited by-同舟云学术

Ribonuclease-Activated Cancer Prodrug

Published:2012-03-08 Issue:4 Volume:3 Page:268-272
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Ellis Gregory A.¹,McGrath Nicholas A.¹,Palte Michael J.¹,Raines Ronald T.¹

Affiliation:

1. Department of Biochemistry, ‡Department of Chemistry, and §Medical Scientist Training Program and Molecular & Cellular Pharmacology Graduate Training Program, University of Wisconsin—Madison, Madison, Wisconsin 53706, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ml2002554

Reference61 articles.

1. Drug Delivery

2. Prodrugs: design and clinical applications

3. Prodrug Strategies in Anticancer Chemotherapy

4. New Methods of Drug Delivery

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bicyclic 5-5 Systems: Four Heteroatoms 1:3;Comprehensive Heterocyclic Chemistry IV;2022

2. Investigation on the solid-phase synthesis of silybin prodrugs and their timed-release;Bioorganic & Medicinal Chemistry;2021-11

3. A 4-aminonaphthalimide-based fluorescent traceable prodrug with excellent photoinduced cytotoxicity;Chemical Communications;2021

4. Computational Proteome-Wide Study for the Prediction of Escherichia coli Protein Targeting in Host Cell Organelles and Their Implication in Development of Colon Cancer;ACS Omega;2020-03-30

5. The stilbene derivatives, nucleosides, and nucleosides modified by stilbene derivatives;Bioorganic Chemistry;2019-09